InsightsStrategy & Competition

The S&P 500 used to be a 33-year club. Now the average tenure is 15 years, and by 2027 it's 12.

By Uttam Dinodia2 min readView this post on LinkedIn

Half the index will be gone within a decade.

So, can we please stop teaching "sustainable competitive advantage" like it's still 1985?

Here's the uncomfortable part: the framework everyone quotes is the one quietly betraying them.

Porter and Barney told us that the advantage comes from resources that are Valuable, Rare, Inimitable, and Non-substitutable (VRIN). Build the moat. Defend it. Compound for decades.

Beautiful theory. It's also why so many "defensible" companies got flattened.

In 2013, Columbia's Rita McGrath called it: "Sustainable advantage is dead. The real game is transient advantage." Capture an opportunity fast, exploit it decisively, then walk away before the imitators show up.

Most leaders miss the shift because they're watching the wrong competitor.

Kotler mapped four levels of competition:

  1. Product: Diet Pepsi vs Diet Coke
  2. Category: all soft drinks
  3. Generic: all drinks
  4. Budget: share of wallet

Most competitive intelligence scans Level 1. Almost every disruption arrives at Level 4.

Blockbuster watched Hollywood Video. The threat was Netflix.
Newspapers watched newspapers. The threat was Craigslist.
Britannica watched World Book. The threat was Wikipedia.

None of them lost to a rival they were tracking. They lost to a category they didn't think was their problem.

So if your edge has an expiry date (and it does), three rules for the transient era:

  1. Build for renewal, not defence. Plan to retire your edge before someone retires it for you.
  2. Scan all four levels, not just your direct rivals.
  3. Hold strategy loosely. Hold execution tightly.

Sustainable advantage was never a fortress. It's a series of well-timed bets.

Genuinely curious how others see this: which of your current advantages do you think has the shortest shelf life left, and what's the next bet?

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.